NPCE vs STT · rev $22.8M vs P/E 17, rev $7.84B
Neuropace Inc (NPCE) versus State Street Corp (STT) — a side-by-side from cached financials, not a winner call.
Neuropace Inc (NPCE) is a medical devices company listed on US.
State Street Corp (STT) is a asset management company listed on US.
Latest reported NPCE revenue for 2026-06-30 was $22.8M. Net income was -$6.2M. Revenue was up 3.4% from 2026-03-31 to 2026-06-30. NPCE currently screens at market cap $312.2M.
Latest reported STT revenue for 2026-06-30 was $7.84B. Net income was $1.85B. STT currently screens at market cap $45.02B and trailing P/E 16.5.
NPCE currently screens at market cap $312.2M. STT currently screens at market cap $45.02B and trailing P/E 16.5.
Not investment advice. Open the NPCE and STT stock pages for the full models.
Not investment advice.